OTC Markets Group Inc. today announced MPX Bioceutical Corporation (CSE: MPX; OTCQX: MPXEF), a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets, has qualified to trade on the OTCQX® Best Market.
NEW YORK, Oct. 10, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced MPX Bioceutical Corporation (CSE: MPX; OTCQX: MPXEF), a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets, has qualified to trade on the OTCQX® Best Market. MPX Bioceutical Corporation upgraded to OTCQX from the OTCQB® Venture Market.
MPX Bioceutical Corporation begins trading today on OTCQX under the symbol “MPXEF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
“We are pleased to welcome MPX Bioceutical Corporation, the 30th company this year to graduate to the OTCQX Best Market from the OTCQB Venture Market,” said Jason Paltrowitz, Executive Vice President of OTC Markets Group. “A member of the CSE25, an index composed of the largest CSE-listed companies, MPX Bioceutical Corporation cross-trades on the OTCQX Market alongside established, investor-focused international companies. Trading on both the CSE in Canada and the OTCQX Market in the U.S. will enable MPX Bioceutical Corporation to efficiently build global investor awareness and enhance disclosure in the U.S.”
W. Scott Boyes, MPX’s Chairman, President and CEO, commented, “Upgrading to the OTCQX Market will bolster our profile and enable more investors to participate in MPX’s growth and development as we execute on our multi-state expansion strategy in the cannabis market. MPX is entering a new chapter in its growth, and we are pleased to take this step to generate added liquidity in our stock and build shareholder value.”
MPX Bioceutical Corporation was sponsored for OTCQX by SecuritiesLawUSA, PC, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.
About MPX Bioceutical Corporation
MPX Bioceutical Corporation (formerly known as the Canadian Bioceutical Corporation) is a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets. The company’s foundation is built on its profitable operations in Arizona, with three (and soon four), operating dispensaries and well the established Melting Point Extracts (MPX) Brand; it also has operations in Massachusetts, Maryland, and Nevada. MPX Bioceutical Corporation plans to replicate its success in Arizona to become a dominant multi-state operator.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
OTC Link ATS and OTC Link ECN are operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-mpx-bioceutical-corporation-to-otcqx-300728241.html
SOURCE OTC Markets Group Inc.
Company Codes: OTC-PINK:OTCM, CNSX:MPX, OTC-PINK:MPXEF, OTC-QX:MPXEF, OTC-QX:OTCM
